RITONAVIR INTERACTIONS AND SIDE EFFECTS Present by PEERAKARN BANJERDKIJ.

Slides:



Advertisements
Similar presentations
Slide #1 HIV Entry Inhibitors Trip Gulick, MD, MPH Director, Cornell HIV Clinical Trials Unit Associate Professor of Medicine Weill Medical College of.
Advertisements

April 15 Understanding HIV Treatment and adherence. The African Eye Trust HIV Treatment Information Event By Badru Male&Elijah Amooti.
HAART Highly Active Antiretroviral Therapy
How do the Anti-HIV drugs woks? By Tawitch Suriyo Master degree of Toxicology Mahidol University.
HIV AND HIV MUTANTS E. Chigidi and E. Lungu University of Botswana Private Bag 0022 Gaborone, Botswana.
ANTIRETROVIRAL THERAPY Dr. Samuel Mwaniki (BPharm., MSc TID, UoN) University of Nairobi ISO 9001: Certified
Treatment of AIDS “Antiretroviral therapy & vaccines”
1 Antiviral Drugs Limited selective toxicity –Viruses mostly use host cell machinery, so very few unique targets –Most drugs block steps that take place.
Dr Emmanuel Nsutebu Consultant Infectious Diseases Physician Tropical and Infectious Diseases Unit Royal Liverpool Hospital HIV “Myths, controversies and.
Human Immunodeficiency Virus and Antiretroviral Therapy
1 Inhibitors of Other Viruses A. RIBAVIRIN Ribavirin (Virazole) is a nucleoside analogue in which a triazolecarboxamide moiety is substituted on place.
Guadalupe Compean Diana Martinez Thu Ton
Hormonal Contraceptives – Considerations for Women with HIV and AIDS.
Presented by: Siti Rohaizah bt Othman. Arv DRUGS AVAILABLE IN UMMC Combivir (Lamivudine + Zidovudine) Stocrin (Efavirenz 600mg) Kaletra (Lopinavir 200mg.
HIV/ AIDS Guadalupe Compean Diana Martinez Thu Ton.
Anti-HIV Drugs Cathy Molina November 11, Some HIV Facts HIV – the Human Immunodeficiency Virus is the retrovirus that causes AIDS HIV belongs to.
Antiviral Drugs: HIV treatment Zach Laucis April 17 th, 2007.
Combination Antiretroviral Therapy for HIV Infection by Ormrat Kampeerawipakorn.
ANTIRETROVIRAL RESISTANCE Jennifer Fulcher, MD, PhD.
Antivirals for HIV Yasir Waheed, PhD. Some HIV Facts HIV – the Human Immunodeficiency Virus is the retrovirus that causes AIDS HIV belongs to the retrovirus.
KITSO AIDS Training Program
Session 3: Nutrition and HIV Medications
Clinical group Marketing group Production group New Approach group Ethics group Final Presentation.
Introduction to ARV therapy
Footprint-based identification of viral entry inhibitors targeting HIVgp41 Mr. Holden 9/18/2012.
HIV:HCV Co-infection Landscape 21 of October, 09 Madrid,Spain GESIDA, Madrid.
Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc. Chapter 93 Antiviral Agents II: Drugs for HIV Infection and Related.
Aids Facts About Prevention. Disease Facts Found in tears, saliva,nervous system tissue, spinal fluid, and breast milk.
1 Review of Antiretroviral Therapy in Adults HAIVN Harvard Medical School AIDS Initiative in Vietnam.
© IAS–USA Johnson VA et al. Top Antivir Med. 2011;19(4): Updates, user notes, and references available at Mutations in the.
WHO - PSM 14/7/2005 Principles for selection of medicines Dr Mary R. Couper Quality Assurance and Safety of Medicines WHO.
Virsuses: Human Immunodeficiency Syndrome & Acquired Immunodeficiency Syndrome.
Anti-HIV Drugs Melissa Morgan Medicinal Chemistry November 23, 2004.
Is HIV and AIDS the same thing? HIV “Human Immunodeficiency Syndrome” A specific type of virus (a retrovirus) HIV invades the helper T cells to replicate.
Dr.Abdul latif Mahesar. How HIVpositive differs from AIDS Does in every case HIV leads to AIDS ?
Predicting NNRTI Resistance – do polymorphisms matter? Nicola E Mackie 1, Lucy Garvey 1, Anna Maria Geretti 2, Linda Harrison 3, Peter Tilston 4, Andrew.
1 ARV Drug Resistance HAIVN Harvard Medical School AIDS Initiative in Vietnam.
HIV i-Base: Training for Advocates, 10/2004www.i-Base.info Section 3: Introduction to ARV Therapy HIV i-Base STEP EATG HIV Training for Advocates.
TO EVALUATE EARLY ANTIVIRAL RESPONSE AND SAFETY OF A DUAL BOOSTED PROTEASE INHIBITORS REGIMEN INCLUDING LOPINAVIR/r (LPV) PLUS AMPRENAVIR (AMP) OR FORTOVASE.
1 Introduction to ARV Therapy HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Antiviral Drugs Prof. Alhaider, 1431 H Definition: Viral infections depend on the host cells. Therefore, antiviral drugs must block viral entry or exit.
Intellectual Property Law FDA Thailand Health Insurance in Thailand.
Insert Program or Hospital Logo Introduction The current preferred prenatal regimen to reduce mother-to-child human immune deficiency virus (HIV) transmission.
Immune System Immune System protects organisms from disease T-Cells are a type of white blood cell that are used by the immune system to fight pathogens.
Is HIV and AIDS the same thing? HIV “Human Immunodeficiency Syndrome” A specific type of virus (a retrovirus) HIV invades the helper T cells to replicate.
HIV-1 dynamics Perelson et.al. Science 271:1582 (1996) Infected CD4 + lymphocytes Uninfected, activated CD4 + lymphocytes HIV-1 t 1/ days t 1/2.
Anti-viral Drugs.. Introduction The viral agents kill viruses by inhibiting their ability to replicate, but there are currently only about a dozen such.
ARV Therapy Basics in the Context of Family Planning
PK-PD relationships for antiretroviral drugs Richard M.W. Hoetelmans, PharmD, PhD Slotervaart Hospital Dept. of Pharmacy & Pharmacology Amsterdam, The.
Highly Active Antiretroviral Therapy (HAART) Cocktail Therapy
HIV Life Cycle Step 1: Fusion Step 2: Transcription reverse transcriptase Step 3: Integration Step 4: Cleavage Step 5: Packaging and Budding HIV.
HIV: WHAT IS NEW? DR NYA EBAMA, M.D. LOWCOUNTRY INFECTIOUS DISEASES, PA CARETEAM PLUS, INC SEPTEMBER 18, 2015.
Antiretroviral targets in the viral life cycle Viral Replication and Drug targets.
The Nature of Viruses Chapter 27.
11 INTRODUCTION TO ANTIRETROVIRAL THERAPY (ART) IN CHILDREN: INITIATION AND MONITORING HAIVN Harvard Medical School AIDS Initiatives in Vietnam.
Side effects of antiretroviral drugs
Basics of Human Immunodeficiency Virus (HIV) Brian Rybarczyk, PhD University of North Carolina- Chapel Hill.
Immune reconstitution Anjie Zhen, PhD
The HIV virus. Objectives At the end of this session the participants will be able to: 1. Understand basic HIV structure 2. Describe the significance.
General, Organic, and Biological Chemistry Copyright © 2010 Pearson Education, Inc Viruses Chapter 21 Nucleic Acids and Protein Synthesis.
Cellular immune control of Human Immunodeficiency Virus (HIV) Dr. Ali Jalil Ali College of pharmacy.
 The Life Cycle of HIV  Step 1: Binding and Fusion  Drugs which affect this: › Fusion inhibitors › CCR5 Inhibitors
Retrovirus HIV (humans) Animal viruses resulting in cancer / AIDS 15-39%
© IAS–USA Johnson VA et al. Top Antivir Med. 2013;21(1):4-12. Updates, user notes, and references available at Mutations in the Reverse.
Virology – Antivirals 2 JU- 2 nd Year Medical Students By Dr Hamed AlZoubi – Microbiology and Immunology Department – Mutah University. MBBS (J.U.S.T)
Copyright © 2016, 2013, 2010 by Saunders, an imprint of Elsevier Inc. All rights reserved. Chapter 94 Antiviral Agents II: Drugs for HIV Infection and.
Figure 1 Inclusion criteria, exclusion criteria, and criteria for virologic failure. CDC, Centers for Disease Control and Prevention; ddC, zalcitabine;
Clinical and virologic follow-up in perinatally HIV-1-infected children and adolescents in Madrid with triple-class antiretroviral drug-resistant viruses 
School of Pharmacy, University of Nizwa
Antiretroviral therapy and its complications
Presentation transcript:

RITONAVIR INTERACTIONS AND SIDE EFFECTS Present by PEERAKARN BANJERDKIJ

OUTLINE Introduction HIV Therapy Types of HIV-drugs Protease Inhibitors work Ritonavir Pharmacology Drug Interactions Side effects Conclusion

INTRODUCTION Why is the “HIV Therapy” called “multiple therapies”? Ans. : Immune system What is the “medical problem”? Ans. : Drug interactions How many types of HIV-drugs? Ans. : 3 Types

Types of HIV-drugs 2 main groups 1. Reverse Transcriptase 1.1 Nucleoside Reverse Transcriptase Inhibitors (NRTIs) zidovudine (AZT) didanosine (ddI) 1.2 Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs) nevirapine delaviridine 2. Protease Inhibitors (PIs) indinavir ritonavir

What is HIV protease?

How do protease inhibitors work?

How do protease inhibitors differ from other available anti-HIV drugs?

OUTLINE Introduction Ritonavir Pharmacology Drug Interactions Side effects

Pharmacology Block maturation of virus By interfering Act at the stage of HIV replication cycle Produce resistance Bound plasma 98-99% Cross resistance combine with NNRTIs or NRTIs combine with PIs Cross resistance RITONAVIR

OUTLINE Introduction Ritonavir Pharmacology Drug Interactions Side effects

What types of other medications can interact with PIs? Ans.1 : HIV-HIV drugs - Combination Therapy - Double-Drug ; PIs + PIs, PIs + NRTIs - Triple-Drug ; PIs+PIs+NNRTIs Ans.2 : HIV-Other drugs ; PIs+Antivirals Combinations & Interactions RITONAVIR

Drug Interactions Metabolized by P450 at the liver Combine with competition drugs ; can occur 1. Metabolism of these drugs 2. Concentration of Ritonavir and these drugs RITONAVIR

Between Other drugs and Ritonavir DRUG INTERACTION

Between Other drugs and PIs DRUG INTERACTION

Between PIs and PIs * Invirase or Fortovase, + Conducted with Invirase, # with Fortovase DRUG COMBINATION

OUTLINE Introduction Ritonavir Pharmacology Drug Interactions Side effects

Adverse Drug Reaction SIDE EFFECTS

HIV Drugs -Toxicities SIDE EFFECTS

OUTLINE Introduction Ritonavir Pharmacology Drug Interactions Side effects Conclusion

CONCLUSIONS Protease Inhibitors can cure or not! Combination ; more efficiency Side effects ; different ways Resistance Problems Cross resistance problems

THE END THANK YOU Dr. SUVITDr. SUVIT Dr. MARIADr. MARIA Mr. SOMJERDMr. SOMJERD CRI OFFIER & OUR CLASSCRI OFFIER & OUR CLASS……...

Advantages & Disadvantages of Class-Sparing Regimens SIDE EFFECTS